1	Subject is currently treated with carbamazepine phenytoin primidone or phenobarbital or any other drug known to induce CYP3A4 liver enzymes Subject is taking tiagabine felbamate or vigabatrin Subject is taking benzodiazepines zolpidem zaleplon or zopiclone 3 times per week for any indication|primidone[58,67]|||||||||C0033148|8691|8691|primidone
1	Subject is currently treated with carbamazepine phenytoin primidone or phenobarbital or any other drug known to induce CYP3A4 liver enzymes Subject is taking tiagabine felbamate or vigabatrin Subject is taking benzodiazepines zolpidem zaleplon or zopiclone 3 times per week for any indication|phenytoin[48,57]|||||||||C0031507|8183|8183|phenytoin
1	Subject is currently treated with carbamazepine phenytoin primidone or phenobarbital or any other drug known to induce CYP3A4 liver enzymes Subject is taking tiagabine felbamate or vigabatrin Subject is taking benzodiazepines zolpidem zaleplon or zopiclone 3 times per week for any indication|carbamazepine[34,47]|||||||||C0006949|2002|2002|carbamazepine
1	Subject is currently treated with carbamazepine phenytoin primidone or phenobarbital or any other drug known to induce CYP3A4 liver enzymes Subject is taking tiagabine felbamate or vigabatrin Subject is taking benzodiazepines zolpidem zaleplon or zopiclone 3 times per week for any indication|phenobarbital[71,84]|||||||||C0031412|8134|8134|phenobarbital
1	Subject is currently treated with carbamazepine phenytoin primidone or phenobarbital or any other drug known to induce CYP3A4 liver enzymes Subject is taking tiagabine felbamate or vigabatrin Subject is taking benzodiazepines zolpidem zaleplon or zopiclone 3 times per week for any indication|felbamate[168,177]|||||||||C0060135|24812|24812|felbamate
1	Subject is currently treated with carbamazepine phenytoin primidone or phenobarbital or any other drug known to induce CYP3A4 liver enzymes Subject is taking tiagabine felbamate or vigabatrin Subject is taking benzodiazepines zolpidem zaleplon or zopiclone 3 times per week for any indication|tiagabine[158,167]|||||||||C0068897|31914|31914|tiagabine
1	Subject is currently treated with carbamazepine phenytoin primidone or phenobarbital or any other drug known to induce CYP3A4 liver enzymes Subject is taking tiagabine felbamate or vigabatrin Subject is taking benzodiazepines zolpidem zaleplon or zopiclone 3 times per week for any indication|zaleplon[235,243]|||||||||C0251504|74667|74667|zaleplon
1	Subject is currently treated with carbamazepine phenytoin primidone or phenobarbital or any other drug known to induce CYP3A4 liver enzymes Subject is taking tiagabine felbamate or vigabatrin Subject is taking benzodiazepines zolpidem zaleplon or zopiclone 3 times per week for any indication|zolpidem[226,234]|||||||||C0078839|39993|39993|zolpidem
1	Subject is currently treated with carbamazepine phenytoin primidone or phenobarbital or any other drug known to induce CYP3A4 liver enzymes Subject is taking tiagabine felbamate or vigabatrin Subject is taking benzodiazepines zolpidem zaleplon or zopiclone 3 times per week for any indication|benzodiazepines[210,225]||||||||||1402|1402|benzodiazepines
1	Subject is currently treated with carbamazepine phenytoin primidone or phenobarbital or any other drug known to induce CYP3A4 liver enzymes Subject is taking tiagabine felbamate or vigabatrin Subject is taking benzodiazepines zolpidem zaleplon or zopiclone 3 times per week for any indication|vigabatrin[181,191]|||||||||C0048044|14851|14851|vigabatrin
1	Subject is currently treated with carbamazepine phenytoin primidone or phenobarbital or any other drug known to induce CYP3A4 liver enzymes Subject is taking tiagabine felbamate or vigabatrin Subject is taking benzodiazepines zolpidem zaleplon or zopiclone 3 times per week for any indication|zopiclone[247,256]||||||3 times per week[257,273]|||C0078847|40001|40001|zopiclone
